BIOMET INC
8-A12B, 2000-01-05
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: BIOMET INC, 8-K, 2000-01-05
Next: JACKPOT ENTERPRISES INC, SC 13D/A, 2000-01-05



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549-1004

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934

BIOMET, INC.
(Exact name of registrant as specified in its charter)

Indiana                                        35-1418342
(State or other                                (IRS Employer
jurisdiction of                                Identification Number)
incorporation)

Airport Industrial Park                             46581-0587
P.O. Box 587                                        (Zip Code)
Warsaw, Indiana
(Address of principal
executive offices)

Securities to be registered pursuant to Section 12(b) of the Act:

    Title of each class                       Name of each exchange on which
    to be so registered                       Each class is to be registered

    None                                      None

If this Form relates to the  registration  of a class of debt  securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check the
following box. [ ]

If this Form relates to the registration of a class of debt securities and is to
become  effective   simultaneously   with  the  effectiveness  of  a  concurrent
registration  statement  under the  Securities  Act of 1933  pursuant to General
Instruction A.(c)(2), please check the following box. [ ]

Securities to be registered pursuant to Section 12(g) of the Act:

Preferred Stock Purchase Rights
- -------------------------------
(Title of class)

<PAGE>

Item 1.  Description of Registrant's Securities to be Registered

     The Board of  Directors  has  adopted a new  Shareholder  Rights  Plan (the
"Plan") to replace a 1989  rights plan that  expired on  December  2, 1999.  The
purpose of the Plan is to deter certain  coercive tactics that have been used to
acquire control of public  corporations  and to enable the Board of Directors to
represent  effectively  the  shareholders'  interests in the event of a takeover
attempt.  The Plan will not deter  negotiated  mergers or business  combinations
that the Board of Directors determines to be in the shareholders' best interests
and in the best interests of Biomet, Inc. (the "Company").  The Plan is designed
to force an  acquiror  to deal with the Board of  Directors.  If the  acquiror's
proposal is not approved by the Board,  the issuance of the Rights  provided for
in the Plan  would  dramatically  alter the  capital  structure  of the  Company
thereby making the acquiror's  proposal  unattractive  to it. The involvement of
the Board of  Directors  could  improve  the price and terms of any  acquisition
proposal.  The  adoption  of  the  Plan  is  not in  response  to  any  specific
acquisition  proposal and the Company is not aware of plans or proposals for the
acquisition  of control of the  Company.  The Plan does not in any way alter the
financial  strength of the Company or  interfere  with its business  plans.  The
adoption of the Plan is not  dilutive,  does not affect  reported  earnings  per
share, and is not taxable to the shareholders or the Company.

     To  implement  the Plan the Board of  Directors  declared a dividend of one
preferred share purchase right (a "Right") for each outstanding  common share of
the Company (the "Common  Shares").  The dividend is payable to  shareholders of
record on  December  28,  1999 (the  "Record  Date").  Each Right  entitles  the
registered  holder to purchase from the Company one one-hundred  thousandth of a
Preferred  Share  (the  "Preferred  Share  Units")  at a price  of  $175.00  per
Preferred  Share  Unit  (the  "Purchase  Price"),  subject  to  adjustment.  The
description  and terms of the  Rights are set forth in a Rights  Agreement  (the
"Rights Agreement") between the Company and Lake City Bank, as Rights Agent (the
"Rights Agent").

Rights Attach to Common Shares Initially

     Initially and until a  Distribution  Date (as defined  below)  occurs,  the
Rights are  attached to all Common  Shares and no separate  Rights  certificates
will be issued. During this initial period, the Rights are not exercisable;  the
Rights  are  transferred  with  the  Common  Shares  and  are  not  transferable
separately from the Common Shares; new Common Shares  certificates or book entry
shares  issued will  contain a notation  incorporating  the Rights  Agreement by
reference;  and the  transfer  of any Common  Shares  will also  constitute  the
transfer of the Rights associated with those Common Shares.

<PAGE>


Distribution of Rights

     Separate  certificates  evidencing  the Rights will be mailed to holders of
record of the Common Shares on the "Distribution Date." The Distribution Date is
the earlier to occur of the  following  two events (or such later date as may be
determined by the Board of Directors):

     -    10  business  days  following a public  announcement  that a person or
          group of affiliated or associated persons (an "Acquiring Person") have
          acquired beneficial ownership of 15% or more of the outstanding Common
          Shares; or

     -    10 business days (or such later date as may be determined by action of
          the Board of  Directors  prior to such time as any  Person  becomes an
          Acquiring  Person) after the  commencement  of, or  announcement of an
          intention to make, a tender offer or exchange  offer the  consummation
          of which would result in the beneficial ownership by a person or group
          of 30% or more of such outstanding Common Shares.

     Acquisitions  by the  following  persons  will  not  result  in the  person
becoming an Acquiring  Person:  the Company,  any subsidiary or employee benefit
plan of the  Company,  or any other  person  approved in advance by the Board of
Directors.

     After the Distribution  Date, the Rights will be tradeable  separately from
the Common Shares.  After the Distribution Date and after the Company's right to
redeem (as described  below) has expired,  the Rights will be exercisable in two
different ways depending on the circumstances as set forth below.

Right to Purchase Company Shares

     After the  Distribution  Date and after the Company's  redemption right has
expired,  each holder of a Right (except those held by the Acquiring  Person and
its affiliates and associates)  will have the right to purchase,  upon exercise,
that  number of Common  Shares (or, in certain  circumstances,  Preferred  Share
Units or other similar  securities of the Company)  having a market value of two
times the exercise price of the Right, in lieu of such Common Shares, subject to
the availability of a sufficient number of authorized but unissued Common Shares
(such right being called the "Subscription  Right"). The Subscription Right will
be  exercisable  for a 60-day period after the effective  date of a registration
statement  under the  Securities  Act of 1933,  as amended,  covering the Common
Shares.

Right to Purchase Acquiring Person Shares

     Alternatively,  if the Company is  acquired  in a merger or other  business
combination  transaction  or 50% or more of its  consolidated  assets or earning
power  are  sold,  each  holder  of a Right  will  thereafter  have the right to
receive,  upon the exercise  thereof at the then current  exercise  price of the
Right,  that number of shares of common stock of the acquiring  company which at
the time of such  transaction will have a market value of two times the exercise
price of the Right (such right being called the "Merger Right").  Each holder of
a Right (other than an Acquiring  Person) will continue to have the Merger Right
whether or not such holder exercises the Subscription Right.


<PAGE>

Exchange of Company Shares for Rights

     At any time after the  acquisition  by a person or group of  affiliated  or
associated  persons of  beneficial  ownership of 15% or more of the  outstanding
Common Shares or the announcement of a tender or exchange offer resulting in the
beneficial  ownership  by a Person  or  group of 30% or more of the  outstanding
Common Shares and prior to the  acquisition by such Person or group of more than
50%  outstanding  Common  Shares,  the Board of  Directors  of the  Company  may
exchange the Rights  (other than Rights owned by such person or group which have
become void),  in whole or in part, at an exchange ratio of one Common Share per
Right (subject to adjustment).

     With  certain  exceptions,  no  adjustment  in the  Purchase  Price will be
required until  cumulative  adjustments  require an adjustment of at least 1% in
such Purchase Price.  No fractional  Common Shares or Preferred Share Units will
be issued and in lieu  thereof,  an adjustment in cash will be made based on the
market price of the Common  Shares or Preferred  Share Units on the last trading
day prior to the date of exercise.

Adjustment of Shares

     The Purchase  Price  payable,  and the number of  Preferred  Share Units or
other securities issuable, upon exercise of the Rights are subject to adjustment
from time to time to prevent  dilution (i) in the event of a stock  dividend on,
or a subdivision, combination or reclassification of, the Preferred Shares, (ii)
upon the grant to holders of the Preferred  Shares of certain rights or warrants
to  subscribe  for or  purchase  Preferred  Shares  at a  price,  or  securities
convertible  into Preferred Shares with a conversion  price,  less than the then
current market price of the Preferred  Shares or (iii) upon the  distribution to
holders  of  the  Preferred  Shares  of  evidences  of  indebtedness  or  assets
(excluding  regular  periodic  cash  dividends  paid out of earnings or retained
earnings or dividends payable on Preferred Shares) or of subscription  rights or
warrants (other than those referred to above).

     The Purchase  Price  payable,  and the number of  Preferred  Share Units or
other  securities  issuable,  upon  exercise  of the Rights are also  subject to
adjustment  in the  event of a stock  split  of the  Common  Shares,  or a stock
dividend  on the  Common  Shares  payable  in Common  Shares,  or  subdivisions,
consolidations or combinations of the Common Shares occurring, in any such case,
prior to the Distribution Date.

Redemption

     At any time prior to the close of business on the tenth day  following  the
acquisition  by a  person  or group  of  affiliated  or  associated  persons  of
beneficial  ownership  of 15% or more of the  outstanding  Common  Shares or the
announcement of a tender or exchange offer resulting in the beneficial ownership
by a Person or group of 30% or more of the outstanding Common Shares and subject
to extension of the  redemption  period by the Board of Directors,  the Board of
Directors of the Company may redeem the Rights in whole,  but not in part,  at a
price of $.0001 per Right (the "Redemption Price"). The redemption of the Rights
may be made  effective at such time,  on such basis and with such  conditions as
the Board of Directors in its sole  discretion may establish.  Additionally  the
Company may,  following  the time that a person has become an Acquiring  Person,
redeem the then outstanding  Rights in whole, but not in part, at the Redemption
Price provided that such  redemption is (i) in connection with a merger or other
business combination transaction or series of transactions involving the Company
in which all holders of Common  Shares are treated  alike but not  involving  an
Acquiring  Person or any person who was an Acquiring Person or (ii) following an
event  giving  rise to, and the  expiration  of the  exercise  period  for,  the
Subscription Right if and for as long as no person  beneficially owns securities
representing 15% or more of the Company's outstanding Common Shares. Immediately
upon any  redemption  of the  Rights,  the right to  exercise  the  Rights  will
terminate  and the only right of the  holders of Rights  will be to receive  the
Redemption Price.


<PAGE>

Expiration of Rights

     The Rights will expire on December 16, 2009 unless the  expiration  date is
extended by amendment  as  described  below or unless the Rights are redeemed or
exchanged by the Company as described above.

Amendments

     As long as the  Rights  are  redeemable,  the  terms of the  Rights  may be
amended by the Board of  Directors  of the  Company  without  the consent of the
holders of the Rights,  except that no such  amendment may adversely  affect the
interests of the holders of the Rights.

Miscellaneous

     The number of  outstanding  Rights and the number of Preferred  Share Units
issuable  upon  exercise of each Right are subject to  adjustment  under certain
circumstances.

     Because of the nature of the Preferred  Shares'  dividend,  liquidation and
voting  rights,  the value of a Preferred  Share Unit that may be purchased upon
exercise of each Right should approximate the value of one Common Share.

     Until a Right is  exercised,  the  holder  thereof,  as such,  will have no
rights as a shareholder of the Company, including, without limitation, the right
to vote or to receive dividends.

<PAGE>

Item 2.  Exhibits

         Exhibit No.   Description

              3.01     Restatement of the Articles of  Incorporation of  Biomet,
                       Inc.  (Incorporated   by  reference  to  Exhibit  3.01 to
                       Biomet,   Inc.'s  Current  Report  on   Form   8-K  filed
                       January 5, 2000)

              4.01     Rights  Agreement  dated as of December 16, 1999  between
                       Biomet,  Inc.  and  Lake   City  Bank,  as  Rights  Agent
                       (Incorporated by reference  to  Exhibit   4.1 to  Biomet,
                       Inc.'s Current Report on Form 8-K filed January 5, 2000).


SIGNATURE

     Pursuant to the  requirements of Section 12 of the Securities  Exchange Act
of 1934, the registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned hereunto duly authorized.

                                     BIOMET, INC.



                                     By: /s/ Daniel P. Hann
                                        --------------------------------------
                                         Daniel P. Hann, Senior Vice President
                                         and General Counsel

Dated: January 5, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission